While retatrutide mimics three hormones to support weight loss and blood sugar levels, Ozempic only mimics one.
Retatrutide also appears to support more significant weight loss than Ozempic. Research suggests that Ozempic supports an average weight loss of around 6 kg after 40 weeks. On retatrutide, it’s closer to 20kg.
However, Ozempic isn’t approved for weight loss in the UK and can only be prescribed to patients living with type 2 diabetes.
Retatrutide is yet to apply for approval in the UK, Australia or US but it’s likely to be approved for weight loss and type 2 diabetes.
Weightlosschems.com has Retratrutide available for purchase as a research chemical in Australia now.
